Sarcoma, Synovial - 20 Studies Found
Recruiting |
: DHEA in Synovial Sarcoma Patients :
|
Terminated |
: First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10 : Sarcoma, Synovial : 2011-11-03 :
|
Terminated |
: A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma : Synovial Sarcoma : 2005-08-30 : Drug: Anti-CTLA4 (monoclonal antibody MDX-010) |
Recruiting |
: A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma : Synovial Sarcoma : 2011-04-26 : Biological: NY-ESO-1(c259)T Cells Cytoreductive chemotherapy followed by infusion with NY-ESO-1(c259) tr |
Recruiting |
: Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases :
: 2014-07-02 : Radiation: Whole Lung IMRT External beam radiation therapy will be administered on an outpatient basis, |
Not yet recruiting |
: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma :
|
Completed |
: Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma : Sarcoma : 2005-03-03 : Biological: trastuzumab |
Completed |
: Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma : Sarcoma : 2003-01-24 : Drug: gefitinib |
Withdrawn |
: NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma :
: |
Recruiting |
: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma :
|